1800-272-662
Shopping Cart 0
countryflagAU
Login

Doximity Inc

Healthcare US DOCS

24.505USD
-0.275(1.11%)

Last update at 2026-03-11T15:03:00Z

Day Range

24.2225.19
LowHigh

52 Week Range

19.7140.12
LowHigh

Fundamentals

  • Previous Close 24.78
  • Market Cap5214.70M
  • Volume381621
  • P/E Ratio48.14
  • Dividend Yield-%
  • EBITDA149.51M
  • Revenue TTM448.31M
  • Revenue Per Share TTM2.32
  • Gross Profit TTM 365.56M
  • Diluted EPS TTM0.58

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax 133.16M 114.00M 57.77M 23.51M 7.93M
Minority interest - - - - -
Net income 112.82M 154.78M 50.21M 29.74M 7.83M
Selling general administrative 36.74M 35.75M 16.49M 7.44M 7.34M
Selling and marketing expenses 123.52M 92.13M 62.03M 39.45M 33.05M
Gross profit 365.56M 303.76M 175.70M 101.49M 74.81M
Reconciled depreciation 10.28M 5.04M 3.70M 0.90M 0.55M
Ebit 125.11M 113.54M 53.30M 22.16M 6.92M
Ebitda 135.39M 118.58M 57.01M 23.06M 7.47M
Depreciation and amortization 10.28M 5.04M 3.70M 0.90M 0.55M
Non operating income net other - - - - -
Operating income 125.11M 113.54M 53.30M 22.16M 6.92M
Other operating expenses 293.94M 230.01M 153.59M 94.22M 78.77M
Interest expense 8.05M 0.47M 4.47M 1.35M 1.01M
Tax provision 20.34M -40.77800M 7.56M -6.22300M 0.10M
Interest income - - 0.30M 1.46M 1.07M
Net interest income - - 0.30M 1.46M 1.07M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 20.34M -40.77800M 7.56M -6.22300M 0.10M
Total revenue 419.05M 343.55M 206.90M 116.39M 85.69M
Total operating expenses 240.45M 190.22M 122.40M 79.33M 67.89M
Cost of revenue 53.49M 39.79M 31.20M 14.90M 10.89M
Total other income expense net 8.05M 0.47M 4.47M 1.35M -0.05900M
Discontinued operations - - - - -
Net income from continuing ops 112.82M 154.78M 50.21M 29.74M 7.83M
Net income applicable to common shares 112.82M 176.31M 21.56M 10.83M 0.59M
Preferred stock and other adjustments - - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 1136.89M 991.36M 251.72M 138.92M -
Intangible assets 31.84M 7.91M 9.60M 0.39M -
Earning assets - - - - -
Other current assets 22.29M 24.95M 10.69M 6.95M 2.97M
Total liab 170.77M 112.76M 184.98M 137.78M -
Total stockholder equity 966.12M 878.59M 66.74M 1.14M -
Deferred long term liab - - - - -
Other current liab 31.25M 25.27M 16.29M 8.04M 32.49M
Common stock 0.19M 0.19M 0.08M 0.07M 0.03M
Capital stock 0.19M 0.19M 0.08M 0.07M -
Retained earnings 217.85M 191.11M 36.32M -13.88600M -43.62300M
Other liab 17.38M 1.03M 1.19M 0.29M 0.26M
Good will 67.94M 18.91M 18.91M 0.00000M -
Other assets - 50.82M 4.87M 8.45M 1.43M
Cash 158.03M 112.81M 66.39M 48.43M -
Cash and equivalents - - - - -
Total current liabilities 139.51M 111.28M 102.04M 55.71M 37.81M
Current deferred revenue 105.24M 84.91M 83.27M 44.30M -
Net debt -142.39000M -111.72000M -65.13900M -46.14700M -
Short term debt 1.75M 0.64M 0.97M 1.96M -
Short long term debt - - - - -
Short long term debt total 15.64M 1.09M 1.25M 2.28M -
Other stockholder equity 762.15M -288.76800M 30.36M 14.95M -
Property plant equipment 25.10M 9.57M 8.94M 7.11M 1.37M
Total current assets 975.45M 904.14M 209.40M 122.97M 83.36M
Long term investments - - - - -
Net tangible assets - 851.77M 38.23M 0.74M -33.34200M
Short term investments 682.97M 685.30M 76.14M 38.02M -
Net receivables 107.05M 81.07M 50.32M 26.16M 15.29M
Long term debt - - - - -
Inventory 5.12M - 5.86M 3.41M -
Accounts payable 1.27M 0.46M 1.51M 1.42M 0.94M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -14.08300M -15.29400M -0.02100M -2.24800M -
Additional paid in capital - - - - -
Common stock total equity - - 0.08M 0.07M -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1.65M 2.26M 2.76M 1.35M -
Deferred long term asset charges - - - - -
Non current assets total 161.44M 87.22M 42.32M 15.95M -
Capital lease obligations 15.64M 1.09M 1.25M 2.28M -
Long term debt total - - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments -59.92300M -635.47200M -38.34300M -8.85100M -7.87700M
Change to liabilities 17.53M 10.49M 38.66M 13.80M 5.64M
Total cashflows from investing activities -59.92300M -640.57400M -70.41700M -13.09500M -9.06700M
Net borrowings - - - - -
Total cash from financing activities -74.46100M 560.41M 5.41M 1.72M 0.98M
Change to operating activities -12.12300M -19.80500M -8.17800M -8.03100M -9.27900M
Net income 112.82M 154.78M 50.21M 29.74M 7.83M
Change in cash 45.22M 46.42M 17.96M 14.82M 7.22M
Begin period cash flow 112.81M 66.39M 48.43M 33.61M 26.38M
End period cash flow 158.03M 112.81M 66.39M 48.43M 33.61M
Total cash from operating activities 179.60M 126.58M 82.97M 26.20M 15.31M
Issuance of capital stock 0.00000M 553.90M - 0.00000M -
Depreciation 10.28M 5.04M 3.70M 0.90M 0.55M
Other cashflows from investing activities - 0.59M -0.01200M -0.01200M -0.01200M
Dividends paid - - - - -
Change to inventory - - 1.21M -6.93300M -4.07000M
Change to account receivables -26.24200M -31.01700M -20.45200M -12.03600M 2.53M
Sale purchase of stock -85.32400M -2.69800M -2.02200M 0.00000M 0.00000M
Other cashflows from financing activities 10.86M 9.21M 7.43M -13.09500M 0.98M
Change to netincome - -2.67300M 12.14M -3.23900M 2.90M
Capital expenditures 6.18M 5.70M 4.61M 4.24M 1.19M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -21.03300M -40.33000M 10.03M -6.26900M -1.10500M
Stock based compensation 47.83M 31.44M 7.25M 2.35M 2.34M
Other non cash items 16.47M 16.89M 6.79M 6.58M 5.20M
Free cash flow 173.42M 120.88M 78.36M 21.95M 14.12M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
DOCS
Doximity Inc		 -0.275 1.11% 24.50 48.14 37.45 11.28 5.83 9.69 28.33
GEHC
GE HealthCare Technologies Inc.		 0.42 0.58% 73.16 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A		 -1.3599 0.72% 188.33 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 11.42 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 0.05 0.97% 5.22 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

View All

Profile

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Doximity Inc

500, 3rd Street, San Francisco, CA, United States, 94107

Key Executives

Name Title Year Born
Mr. Jeffrey A. Tangney Co-Founder, CEO & Chairperson 1973
Ms. Anna Bryson Chief Financial Officer 1990
Mr. Paul Jorgensen Chief Revenue Officer 1970
Dr. Nate Gross M.D. Co-Founder & Chief Strategy Officer NA
Ms. Shari Buck Co-founder and SVP People & Ops NA
Mr. Jey Balachandran Chief Technology Officer NA
Mr. Perry Scott Gold Head of Investor Relations NA
Ms. Jennifer W. Chaloemtiarana Gen. Counsel & Corp. Sec. 1968
Jim Rivas Head of Corp. Communications NA
Mr. Bruno Miranda Sr. VP of Engineering NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.